GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Starry Pharmaceutical Co Ltd (SHSE:603520) » Definitions » Short Interest

Zhejiang Starry Pharmaceutical Co (SHSE:603520) Short Interest


View and export this data going back to 2016. Start your Free Trial

What is Zhejiang Starry Pharmaceutical Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Zhejiang Starry Pharmaceutical Co's Short Interest

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Starry Pharmaceutical Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Starry Pharmaceutical Co's Short Interest Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Starry Pharmaceutical Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Zhejiang Starry Pharmaceutical Co's Short Interest falls into.



Zhejiang Starry Pharmaceutical Co (SHSE:603520) Business Description

Traded in Other Exchanges
N/A
Address
No.1 Sitali Avenue, Modern Industrial Gathering District, Zhejiang Province, Xianju County, Taizhou City, CHN, 317306
Zhejiang Starry Pharmaceutical Co Ltd is engaged in R&D, manufacture and marketing of active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series.
Executives
Hu Jin Sheng Director

Zhejiang Starry Pharmaceutical Co (SHSE:603520) Headlines

No Headlines